Moore K, et al. - Researchers conduct this open-label crossover study to evaluate the effects of food on niraparib pharmacokinetics (PK) and safety in patients with recurrent ovarian cancer. Observations reveal no impact of a high-fat meal on the PK profile of niraparib, suggesting that niraparib can be taken with or without food. Niraparib is demonstrated to be safe and well-tolerated.